{
    "organizations": [],
    "uuid": "2d6bcafde017070c6aa8e1dc9e2ab8de6c841044",
    "author": "",
    "url": "https://www.reuters.com/article/brief-strongbridge-biopharma-reports-q4/brief-strongbridge-biopharma-reports-q4-gaap-loss-per-share-0-47-idUSASC09RQR",
    "ord_in_thread": 0,
    "title": "BRIEF-Strongbridge Biopharma Reports Q4 GAAP Loss Per Share $0.47",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 45 AM / Updated 7 minutes ago BRIEF-Strongbridge Biopharma Reports Q4 GAAP Loss Per Share $0.47 Reuters Staff   Strongbridge Biopharma Plc: * REPORTS FULL-YEAR 2017 FINANCIAL RESULTS * Q4 NON-GAAP LOSS PER SHARE $0.31 * Q4 GAAP LOSS PER SHARE $0.47 * Q4 EARNINGS PER SHARE VIEW $-0.32 — THOMSON REUTERS I/B/E/S * SEES FY 2018 REVENUE $16 MILLION TO $19 MILLION * ‍ MACRILEN PRODUCT LAUNCH ON TRACK FOR MID-2018​ * QTRLY ‍NET REVENUES OF $3.0 MILLION​  ",
    "published": "2018-03-12T13:43:00.000+02:00",
    "crawled": "2018-03-12T13:57:12.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "biopharma",
        "report",
        "q4",
        "gaap",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "strongbridge",
        "biopharma",
        "plc",
        "report",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "gaap",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "see",
        "fy",
        "revenue",
        "million",
        "million",
        "macrilen",
        "product",
        "launch",
        "track",
        "qtrly",
        "revenue"
    ]
}